Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 99 of the 102 references it cites were found in a registry or an index.

Understanding the molecular basis and pathogenesis of hereditary optic neuropathies: towards improved diagnosis and management

Open access
Newman, Nancy J, Yu-Wai-Man, Patrick, Biousse, Valérie, Carelli, Valerio · 2023 · The Lancet Neurology

Abstract

Hereditary optic neuropathies result from defects in the human genome, both nuclear and mitochondrial. The two main and most recognised phenotypes are dominant optic atrophy and Leber hereditary optic neuropathy. Advances in modern molecular diagnosis have expanded our knowledge of genotypes and phenotypes of inherited disorders that affect the optic nerve, either alone or in combination, with various forms of neurological and systemic degeneration. A unifying feature in the pathophysiology of these disorders appears to involve mitochondrial dysfunction, suggesting that the retinal ganglion cells and their axons are especially susceptible to perturbations in mitochondrial homoeostasis. As we better understand the pathogenesis behind these genetic diseases, aetiologically targeted therapies are emerging and entering into clinical trials, including treatments aimed at halting the cascade of neurodegeneration, replacing or editing the defective genes or their protein products, and potentially regenerating damaged optic nerves, as well as preventing generational disease transmission.

Overview

Integrity signals

Registry

Crossref · 10.1016/s1474-4422(22)00174-0

Cites

99 of 99 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 102 references

Research works printed but not linked: 6

  1. Liu, 2021, Low vision rehabilitation in improving the quality of life for patients with impaired vision: a systematic review and meta-analysis of 52 randomized clinical trials, Medicine (Baltimore), 100
  2. Klopstock, 2022, Long-term efficacy and safety of idebenone in patients with LHON in the subacute/dynamic phase: results from the LEROS study. Presented at the 2022 Annual Meeting of the Association of Research in Vision and Ophthalmology (ARVO), Invest Ophthalmol Vis Sci, 63, 433
  3. Lloria, 2022, Long-term efficacy and safety of idebenone in patients with LHON in the chronic phase: results from the LEROS study. Presented at the 2022 Annual Meeting of the Association of Research in Vision and Ophthalmology (ARVO), Invest Ophthalmol Vis Sci, 63
  4. Xiao, 2020, First China international gene therapy study in Leber's hereditary optic neuropathy, Mol Ther, 28, 558
  5. Karanjia, 2019, Elamipretide (MTP-131) topical ophthalmic solution for the treatment of Leber's hereditary optic neuropathy. Presented at the 2019 ARVO Annual Meeting, Invest Ophthalmol Vis Sci, 60
  6. Harvey, 2021, Induced pluripotent stem cells for inherited optic neuropathies—disease modelling and therapeutic development, J Neuroophthalmol

Cited by

See all 105

Metadata

Authors
Newman, N. J., Yu-Wai-Man, P., Biousse, V., & Carelli, V.
Affiliations
Emory University (US)
Corresponding author
Newman, Nancy J
Venue
The Lancet Neurology
Publisher
Elsevier BV
Published
2023-02
Volume
22
Issue
2
Pages
172-188
ISSN
1474-4422 (ISSN-L)
OpenAlex
W4296901011
Cited by
97
References
102
Citations by year
2026: 23 · 2025: 25 · 2024: 30 · 2023: 12
FWCI
2.65
Type
journal article
Language
en
Open access
Locations
  • The Lancet Neurology (acceptedVersion)
  • PubMed (publishedVersion)
  • Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
Funders
  • National Institute for Health and Care Research (G1002570)
  • UCL Institute of Ophthalmology, University College London
  • Fondazione Telethon (GGP20115)
  • Ministero della Salute (RF-2018-12366703)
  • Medical Research Council
  • National Eye Institute (P30-EY06360)
  • Moorfields Eye Hospital NHS Foundation Trust
  • Research to Prevent Blindness (NIHR301696)
  • Moorfields Eye Charity (GR001376)
  • Fight for Sight
  • NIHR Cambridge Biomedical Research Centre (BRC-1215-20014)
  • Manchester Biomedical Research Centre
  • Ministero dell’Istruzione, dell’Università e della Ricerca (20172T2MHH)
  • National Institutes of Health
  • Isaac Newton Trust
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
  • Health Sciences › Medicine › Ophthalmology › Glaucoma and retinal disorders
Keywords
hereditary optic neuropathy, Leber's hereditary optic neuropathy, autosomal dominant optic atrophy, mitochondrial dysfunction, retinal ganglion cells, genotype-phenotype correlation, molecular diagnosis, pathogenesis, gene therapy, genome editing, neurodegeneration, optic nerve regeneration, disease transmission prevention
MeSH terms
DNA, Mitochondrial, Humans, Mitochondria, Optic Nerve, Optic Nerve Diseases, Optic Atrophy, Autosomal Dominant, Optic Atrophy, Hereditary, Leber

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Understanding the molecular basis and pathogenesis of hereditary optic neuropathies: towards improved diagnosis and management. https://app.cochat.ai/papers/10.1016/s1474-4422(22)00174-0
The paper
Newman, N. J., Yu-Wai-Man, P., Biousse, V., & Carelli, V. (2023). Understanding the molecular basis and pathogenesis of hereditary optic neuropathies: towards improved diagnosis and management. The Lancet Neurology. https://doi.org/10.1016/s1474-4422(22)00174-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.